Tackling key challenges in the life sciences with advanced biological tools

Abcam develop comprehensive solutions in collaboration with scientific and commercial partners to generate optimized antibodies, other binders and assays to help advance scientific research, diagnostic & therapeutic applications in disease areas including neuroscience, cancer and rare diseases,

Go to the profile of Abcam
Sep 12, 2019
0
0
Page of
Go to the profile of Abcam

Abcam

Abcam partners with life science organisations to co-create novel binders for use in drug discovery, in vitro diagnostics and therapeutics, driven by the Company’s proprietary discovery platforms and world-leading, antibody expertise. By constantly innovating its binders and assays, Abcam is helping advance the global understanding of biology and causes of disease, which enables new treatments and improved health. The Company’s pioneering data-sharing approach gives scientists increased confidence in their results by providing validation, user comments and peer-reviewed citations for its 110,000 products. With eleven sites globally, many of Abcam’s 1,100 strong team are co-located in the world's leading life science research hubs, complementing a global network of services and support. To discover more, please visit www.abcam.com and www.abcamplc.com.

No comments yet.